Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Novavax (Nasdaq: NVAX) will participate in the 44th Annual J.P.

Rhea-AI Summary

Novavax (Nasdaq: NVAX) will participate in the 44th Annual J.P. Morgan Healthcare Conference.

The company will present on Wednesday, January 14, 2026 at 4:30 p.m. Pacific Time in San Francisco, CA. A live webcast will be available on the company's Events & Presentations page at ir.novavax.com, and a replay will be available for 30 days following the presentation.

Argus Jan 7 session

+2.42% close to close Open Argus

Details

News Market Reaction – NVAX

On Jan 7, the day this news came out, NVAX closed 2.42% above the previous close.

Data tracked by StockTitan Argus for the Jan 7 session.

Market Context

This announcement highlights Novavax’s planned presentation at the 44th Annual J.P. Morgan Healthcar...

Analysis

This announcement highlights Novavax’s planned presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at 4:30 p.m. Pacific Time. It continues a pattern of active investor engagement following recent milestones, earnings updates, and cost-reduction moves. Investors may focus on what management discusses at the conference, including progress since Q3 2025 results, collaboration revenue, and execution on announced site consolidation and restructuring plans.

Key Figures

Conference date: January 14, 2026 Presentation time: 4:30 p.m. Pacific Time Webcast replay period: 30 days

Conference date

January 14, 2026

J.P. Morgan Healthcare Conference presentation date

Presentation time

4:30 p.m. Pacific Time

Scheduled Novavax presentation slot

Webcast replay period

30 days

Duration replay will be available on investor relations site

Historical Context

5 past events · Latest: Nov 12

5 events

1. Nov 12

   Conference participation

   24h Move

   -3.2%

   Announcement of Jefferies London Healthcare Conference fireside chat and webcast access.

2. Nov 06

   Earnings update

   24h Move

   -1.3%

   Q3 2025 financial results with $70M revenue and $202M net loss disclosed.

3. Nov 04

   Collaboration milestone

   24h Move

   -5.1%

   Completion of U.S. marketing authorization transfer to Sanofi triggering $25M milestone.

4. Oct 30

   Earnings scheduling

   24h Move

   +0.6%

   Notice of upcoming Q3 2025 earnings call and webcast logistics for investors.

5. Oct 22

   Cost reduction move

   24h Move

   -1.5%

   Maryland site consolidation expected to generate $60M proceeds and $230M savings.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44^th Annual J.P. Morgan Healthcare Conference.

Conference Details:
Presentation
Date:	Wednesday, January 14, 2026
Time:	4:30 p.m. Pacific Time
Location:	San Francisco, CA

A webcast of the presentation will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M^® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information. 

Contacts: 

Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com

Media
Yvonne Sprow
240-720-7804
media@novavax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference-302654454.html

SOURCE Novavax, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Novavax (NVAX) present at the J.P. Morgan Healthcare Conference?

Novavax will present on January 14, 2026 at 4:30 p.m. PT.

Where is Novavax's NVAX presentation at the 44th J.P. Morgan Healthcare Conference?

The presentation will take place in San Francisco, CA as part of the conference program.

How can investors watch Novavax (NVAX) at the J.P. Morgan Healthcare Conference?

A live webcast will be available on the company's Events & Presentations page at ir.novavax.com.

How long will the Novavax (NVAX) webcast replay be available?

A replay of the webcast will be available for 30 days after the presentation.

Will Novavax publish materials or slides for the NVAX J.P. Morgan presentation?

Presentation materials are typically posted on the Events & Presentations page at ir.novavax.com; check that page on or after January 14, 2026.

What is the ticker symbol for Novavax referenced at the conference?

Novavax trades under the ticker NVAX on Nasdaq.